Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 6, 2001, Pages 767-772

  Gestri, D ^a   Baldacci, L ^a   Taiuti, R ^a   Galli, E ^a   Maggi, E ^a   Piccinni, M P ^a   Vergelli, M ^a   Massacesi, L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cerebrospinal fluid; Heteroduplex analysis; Multiple sclerosis; T cell receptor genes

Indexed keywords

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; NERVOUS SYSTEM INFLAMMATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; DNA PRIMERS; FEMALE; GENES, T-CELL RECEPTOR BETA; HETERODUPLEX ANALYSIS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0034987726     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.6.767     Document Type: Article

References (27)

1. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995;32:121-82.
2. Zamvill SS, Steinman L. The lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579-621.
3. Acha-Orbea H, Mitchell DJ, Timmermann L, et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988;54:263-73.
4. Howell MD, Winters ST, Olee T, et al. Vaccination against experimental allergic autoimmune encephalomyelitis with T cell receptor peptides. Science 1989;246:668-70.
5. Vandenbark AA, Hashim G, Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341:541-4.
6. Hafler DA, Fox DA, Manning ME, et al. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of with multiple sclerosis. N Engl J Med 1985;312: 1405-11.
7. Lee SJ, Wucherpfennig KW, Brod SA, et al. Common T cell receptor V β usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 1991;29:33-40.
8. Usuku K, Joshi N, Hatem CJ Jr, et al. Biased expression of T cell receptor genes characterises activated T cells in multiple sclerosis cerebrospinal fluid. J Neurosci Res 1996;45: 829-37.
9. Gran B, Gestri D, Sottini A, et al. Detection of skewed T cell receptor gene usage in the peripheral blood of patients with multiple sclerosis. J Neuroimmunol 1998;85:22-32.
10. Greten TF, Slansky JE, Kubota R, et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax 11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 1998;95:7568-73.
11. Tourtellotte WW. The cerebrospinal fluid in multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, et al, eds. Handbook of clinical neurology, demyclinating diseases. Amsterdam: Elsevier, 1985:79-130.
12. Hemmer B, Gran B, Zhao Y, et al. Identification of candidate T cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 1999;5:1375-82.
13. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2-T lymphocytes. J Immunol 1981; 127:1420-3.
14. Hafler DA, Duby AD, Lee SJ, et al. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1988;167:1313-22.
15. Hafler DA, Saadeh MG, Kuchroo VK, et al. TCR usage in human and experimental demyelinating diseases. Immunol Today 1996;17:152-9.
16. Heard RNS, Teutsch SM, Bennetts BH, et al. Lack of restriction of T cell receptor β variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis. J Neurol Neurosurg Psychiatry 1999;67:585-90.
17. Rotteveel FT, Kokkelink I, van Walbeek HK, et al. Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 1987;15:243-9.
18. Sottini A, Quiros-Roldan E, Albertini A, et al. Assessment of T cell receptor β-chain diversity by heteroduplex analysis. Hum Immunol 1996;48:12-22.
19. Langerak AW, Szczepanski T, van der Burg M, et al. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997;11:2192-9.
20. Maini MK, Casorati G, Dellabona P, et al. T cell clonality in immune responses. Immunol Today 1999;20:262-6.
21. Wack A, Cossarizza A, Heltai S, et al. Age-related modifications of the human α/β T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 1998;10:1281-8.
22. Poser CM, Paty DV, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Piccinni M-P, Beloni L, Livi C, et al. Defective production of both leukemia inhibitory factor and type 2 T helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998;4:1020-4.
25. Davis MM, Bjorkman PJ. T cell antigen receptor genes and T cell recognition. Nature 1988;334:395-402.
26. Kimura N, Toyonaga B, Yoshicai Y, et al. Sequences and diversity of human T cell receptor β chain variable region genes. J Exp Med 1986;164:739-50.
27. Kimura N, Toyonaga B, Yoshicai Y, et al. Sequences and repertoire of the human T cell receptor α and β chain variable region genes in thymocytes. Eur J Immunol 1987;17: 375-83.